Investors are betting on the synthesis of DNA for living and storage

Relatively recently accepted that data can be recorded in DNA sequences. Since it is implemented by nature, then why not take advantage of this technology for the benefit of human development? Also studying the mechanisms of DNA synthesis should result in the emergence of personalized medicine at the level of personal correction genes. The only problem is that the synthesis is long, clean and sustainable strands of DNA ― is a complex process with the use of toxic chemical compounds. Breakthrough may be the so-called enzymatic synthesis of DNA (enzymatic DNA synthesis), when to create the desired sequence are used by enzymes, not "hard" chemistry. Among other companies and research laboratories enzymatic DNA synthesis develops a fairly young company Molecular Assemblies. It was established in 2013, but it is 30 years of experience specialized scientists that formed Molecular Assemblies. It is believed that Molecular Assemblies first proposed commercial method is relatively simple method for the synthesis of long DNA chains. In light of the interest in modifications of the genome and the need for new methods of recording information that could not attract investors. It is reported that in the first Assembly of the series A investment the company was able to raise $12.2 million of funds for development.